Cardiogenic shock teams again tied to lower mortality
September 23, 2021
New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.
Docs fight back after losing hospital privileges, patients, and income
August 10, 2021
Physicians in St. Louis lost their hospital privileges when the hospital entered into an exclusive contract with other physicians. They’re losing patients and money.
DOACs best aspirin after ventricular ablation: STROKE-VT
August 2, 2021
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved.
DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry
July 16, 2021
Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.
Simple risk assessment predicts post-PCI ischemic events
June 15, 2021
Determining if PCI patients have just one or more guideline-based risk features predicts their odds of ischemic events, and can be used to tailor antiplatelet therapy, suggests a real-world analysis.
First risk score to predict bleeding risk after TAVR
June 11, 2021
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
June 1, 2021
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase 2a study.
Infective endocarditis with stroke after TAVR has ‘dismal’ prognosis
May 7, 2021
More than half die during the index hospitalization and two-thirds within the first year, a new study shows.
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.
Colchicine before PCI for acute MI fails to improve major outcomes
March 17, 2021
In STEMI patients scheduled for PCI, preprocedural colchicine fails to improve outcomes in the randomized PodCAST-PCI trial.